Start-Up Spotlight: Fractyl Attacks Insulin Resistance At Its Roots
The company is developing a novel duodenal mucosal resurfacing technology designed to reverse the metabolic process that causes insulin resistance in people with type 2 diabetes.
You may also be interested in...
Led by the Mako surgical robot, Stryker’s third-quarter sales exceeded Wall Street analysts’ expectations as it prepares to complete the $4bn acquisition of Wright Medical.
Ai Biomed’s PTeye helps to identify parathyroid tissue during thyroid surgery. Medtronic ENT also announced the FDA clearance of its NIM Vital electromyographic system for nerve monitoring during surgery.
Boston Scientific’s management believes the ongoing recovery of procedure volumes and new technology will allow it to show revenue growth in the fourth quarter.